FR2717M - - Google Patents

Download PDF

Info

Publication number
FR2717M
FR2717M FR933913A FR933913A FR2717M FR 2717 M FR2717 M FR 2717M FR 933913 A FR933913 A FR 933913A FR 933913 A FR933913 A FR 933913A FR 2717 M FR2717 M FR 2717M
Authority
FR
France
Prior art keywords
hydroxy
carboxamide
coumarin
hydrochloride
diethylamino ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR933913A
Other languages
English (en)
French (fr)
Inventor
Darius Molho
Eugene Boschetti
Louis Fontaine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
LIPHA Liyonnaise Industrielle Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS, LIPHA Liyonnaise Industrielle Pharmaceutique filed Critical LIPHA SAS
Priority to FR933913A priority Critical patent/FR2717M/fr
Application granted granted Critical
Publication of FR2717M publication Critical patent/FR2717M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/44—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
    • C07D311/46—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR933913A 1963-05-07 1963-05-07 Expired FR2717M (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR933913A FR2717M (da) 1963-05-07 1963-05-07

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR933913A FR2717M (da) 1963-05-07 1963-05-07

Publications (1)

Publication Number Publication Date
FR2717M true FR2717M (da) 1964-09-11

Family

ID=8585982

Family Applications (1)

Application Number Title Priority Date Filing Date
FR933913A Expired FR2717M (da) 1963-05-07 1963-05-07

Country Status (1)

Country Link
FR (1) FR2717M (da)

Similar Documents

Publication Publication Date Title
JP2010525083A5 (da)
EP0208623A2 (fr) Utilisation de poly- et oligosaccharides pour l'obtention de médicaments actifs dans les pathologies du tissu conjonctif
JPH06507635A (ja) 病理学的過程の予防および／または治療用組成物
FR2555050A1 (fr) Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine, utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
EP0306422A1 (fr) Nouvelles formes galéniques de béta-2-mimétiques pour administration par voie per- et sublinguale
JPH09500366A (ja) 固形腫瘍及び他の疾患の治療のための薬剤の治療効果を改良する方法
WO1996006623A1 (fr) Compositions antithrombotiques et non hemorragiques a base d'heparine, procede pour leur preparation et applications therapeutiques
FR2460669A1 (fr) Compositions pharmaceutiques a base de rifamycine sv et ses sels adaptes au traitement du rhumatisme articulaire et procede pour leur preparation
JPH11189534A (ja) 免疫学的疾患を治療するためのサリドマイドの静脈内投与形
FR2491475A1 (fr) Procede de preparation de sulfate de chondroitine et composition pharmaceutique contenant ce dernier
CN111848512B (zh) 使用高纯度盐酸罂粟碱制备粉针剂药物组合物
CH683966A5 (it) Composti della classe dei ftalidrazidici come sostanze attive in agenti anti-ipossici e di difesa.
FR2529081A1 (fr) Composition therapeutique a base d'acide 5-hydroxydecanoique ou d'un de ses derives pour le traitement des maladies cardiovasculaires
JP2003246730A (ja) トリプターゼ阻害剤
Dambrova et al. EPR investigation of in vivo inhibitory effect of guanidine compounds on nitric oxide production in rat tissues
JPH02255624A (ja) 血小板凝集抑制剤
EP0970702A1 (en) Brain activators
JPS638337A (ja) 抗血液凝固剤
FR2686251A1 (fr) Composition pour la cicatrisation d'une plaie.
FR2473887A1 (fr) Nouvelle utilisation des precurseurs biochimiques des glucosamino-glycanes et compositions pharmaceutiques et cosmetiques respectives
CN113116885A (zh) 一种茶多酚类化合物在制备抗血栓药物中的应用
FR2622450A1 (fr) Association heparine/dermatane sulfate
BE1004874A4 (fr) Depresseur de l'inhibiteur de l'alpha2-plasmine.
JPS6041612A (ja) 血栓症予防及び治療剤
CN108912142B (zh) 吡咯并苯并恶嗪酮类化合物及其注射剂和在抗血栓中的用途